- Contraception For Teens: Let's Talk About It
- Gounder Gives Lowdown on Ebola, Peptides, and Colorectal Screenings
- ASCO: Pfizer one-ups J&J with Talzenna combo's broad castration-sensitive prostate cancer win
- ASCO: With bispecifics on its heels, Incyte positions Monjuvi combo for first-line DLBCL
- 6 dental technology updates in May
- From clinician to leader: Building confidence, capability and leadership in dentistry
- Operationalizing AI at scale: A practical framework for enterprise-scale success
- 3 key stats on the orthodontist workforce
- Meet the COOs of 10 specialty DSOs
- Data, cross-training, and pipeline development: How health systems are rethinking OR staffing
- How top health systems are redefining the digital patient experience
- ‘The most significant change in 20 years’: Cancer centers prepare for daraxonrasib demand
- A Smooth Handoff From Decision to Dollars: Connecting the Last Mile in Healthcare Payments
- Budget-Strapped Montana Will Stress-Test Trump’s Medicaid Work Rules
- How CEOs actually use hospital rankings — and when they don’t
- What OU Health’s founding CEO learned building a new health system
- Arkansas hospital CEO to step down after 11 years for new role
- The behavioral health workforce pipeline: Where it stands and where it’s headed
- 6 major investments in youth behavioral health
- Coalition for Health AI unveils governance playbook for systems
- 66 health systems ranked by long-term debt
- UnitedHealthcare drops some prior auth requirements for cardiology, orthopedic services
- 8 No Surprises Act shake-ups physicians need to know
- The ASC independence playbook: 3 leaders’ thoughts
- Dr. Rahimah Maina opens new dental practice
- GWU offloaded its $450M physician group problem — why the industry watching
- The gastroenterologist pay gap
- Texas surgery center to double in size, add 2 ORs
- What dental leaders told us in May
- Climate Change: Statement on Proposed Rescission of Climate-Related Disclosure Rules
- Kenyan Court Blocks Trump's Plan To Quarantine Ebola Patients
- What’s going on at the FTC? 3 notes for ASC leaders
- 8 DSOs making headlines
- The physician noncompete battle in 5 key figures
- The physician red flags that can predict a bad ASC partner
- Patient death draws renewed CMS scrutiny at HCA’s Mission Hospital
- Nearly 70% of US counties lack a GI: 13 concerning workforce stats
- Statement of Commissioner Mark T. Uyeda on the Rescission of Climate-Related Disclosure Rules
- A new behavioral health profession is born
- Keynote Remarks at the 2026 Reagan National Economic Forum
- Statement on Proposing Release for Rescission of Climate-Related Disclosure Rules
- Dentists’ pay climbed the most in these 10 states
- Mental Health Disorders Now No. 1 Cause of Disability Worldwide
- Massachusetts AG sues UnitedHealthcare over alleged Medicaid fraud
- UnitedHealthcare to nix nearly two thirds of pediatric prior auths
- Industry Voices—Patients are building a new healthcare system. The industry is finally catching up
- Weekly Rundown—Moffitt Cancer Center expands Reimagine Care's virtual oncology model; Tanner Health deploys AI workforce solution
- Study: LA Canine Outbreak Caused By Low Vaccination Rates, Crowded Boarding
- Ocrelizumab Effective In Slowing Progressive MS, Trial Shows
- Long COVID Might Be Twice As Common As Previously Thought
- In Vaccine-Skeptical California County, A Potential Playbook To Contain Measles
- Heavy Drinking Harms College Students' Brain Power, Study Finds
- A Trump Stronghold Grapples With Health Risks of ICE Detention Sites
- After Her Bout of Amnesia, a $59,000 Billing Dispute Wouldn’t Go Away
- Pharma urged to modernize patient support as young adult cancer rates rise
- Philips adds a spoonful of Disney sugar to ease kids’ MRI anxieties
- MannKind seeks long-awaited sales boost with inhaled insulin approval for kids
- Aetna to launch ‘on demand’ virtual mental health services in 2027
- U of Connecticut dental school reappoints dean for 2nd term
- Michigan dentist charged with Medicaid fraud
- Brand-name drug prices climb after launch in US, fall abroad amid MFN push: report
- ASCO: After Takeda’s defeat, Dizal picks up baton to take on J&J in EGFR lung cancer subtype
- Acadia in the headlines: 6 things to know
- 26 behavioral health executive moves to know
- AstraZeneca gains 2nd bladder cancer nod in key expansion for Imfinzi
- Advocate Health grows Q1 revenue by 10.8% amid higher volumes, greater efficiency
- Behavioral health hospital operator to pay $32M in Medicare fraud settlement
- Bangladesh Measles Surge Kills 500+ Children; Vaccine Delays Blamed
- Care navigation startup Garner Health banks $100M series E at $2.74B valuation
- HCA bolsters workforce pipeline with healthcare professional college acquisition
- Plant-Based Diet May Cut Obesity Risk For Women In Menopause
- Pharma leaders meet with PM Takaichi in push for Japan to retain R&D edge
- Penn Medicine, K Health partner to deploy AI clinical agents
- CVS restores coverage of Eli Lilly obesity med Zepbound, adds new pill Foundayo
- CVS restores coverage of Eli Lilly obesity med Zepbound, adds new pill Foundayo
- CMS finalizes changes to No Surprises Act dispute resolution process
- Smartwatch App Accurately Detects Major Epileptic Seizures
- Racial Gap Exists For Asthma Inhaler Use
- New Colon Cancer Screening Guidelines Add Blood And At-Home Tests
- Fierce Pharma Asia—More China biotech hawkishness; Pfizer’s $10B Innovent deal; Astellas’ roadmap
- CVS expands partnership with Salesforce for greater call center personalization
- Nurse Convicted In Patient's Death Turns Fatal Drug Error Into Cautionary Tale
- Wearable Ultrasound Patch Monitors High-Risk Pregnancies In Real Time
- Listen to the Latest ‘KFF Health News Minute’
- In a Vaccine-Skeptical California County, a Potential Playbook To Contain Measles
- Teladoc Health inks partnership with Walmart to expand virtual care services
- PharmaEssentia taps Incyte alum Eric Vogel as it eyes Besremi expansion
- Kaléo speaks up on allergy awareness to amplify patient stories
- Privacy and PetShops: Remarks at the Regulatory PETshop Series: Cryptographic Technologies and Financial Services Regulation
- NYC Health + Hospitals adds 2nd behavioral health housing site
- Mindfulness isn’t a perk anymore — it’s a workforce strategy
- With Elahere building steam, AbbVie nets FDA nod for another ImmunoGen cancer asset
- Hospitals again ask FTC, DOJ for exemption from expanded premerger notification filings
- Coalition for Health AI unveils governance playbooks for responsible AI adoption
- Amazon taps Roy Schoenberg to lead healthcare business as Neil Lindsay plans to step down
- Viridian, awaiting FDA decision, taps WuXi Bio in eye drug supply deal
- U.S. To Keep Ebola-Exposed Citizens In Kenya Under New Policy
- CAT on a Hot Tin Roof
- GLP-1 Meds May Help Slow the Spread of Certain Obesity-Related Cancers
- GoodRx launches subscription program for low-cost generic medications, telehealth services
- George Washington University locks deal to hand off debt-ridden physician practice to UHS
- Humana invests $83M in new Florida pharmacy distribution center
- As J&J separates from its orthopedics business, it's laying off 56 employees in New Jersey
- ASCO preview: With expectations jacked up, Akeso's ivonescimab to face scrutiny in high-stakes plenary
- An insider’s look at LillyDirect
- GLP-1 manufacturer CordenPharma strikes deal for peptide CDMO, lining up new production sites in US and China
- Weight-Loss Program Helps Women Battling Breast Cancer
- Younger U.S. Women of Color Face Rising Breast Cancer Deaths
- High Fitness Doesn’t Raise A-fib Risk In Young Men, Study Finds
- Cheaper, Alternative Health Plans Are Having A Moment, But Critics Urge Caution
- Ultrafine Wildfire Smoke Particles May Pose Serious Health Risks
- Montana Hurries To Adopt Trump’s Medicaid Work Rules Amid Budget Woes
- Readers Address Drugged Driving, Suicide Prevention, Worker Shortages
- Nurse Convicted in Patient’s Death Turns Fatal Drug Error Into a Cautionary Tale
- Amid policy and pricing headwinds, US healthcare and life sci faces 'vast field of opportunity': survey
- Amid policy and pricing headwinds, US healthcare and life sci faces 'vast field of opportunity': survey
- Biogen investigated by Italian regulator over multiple sclerosis ‘market abuse’ claims
- FDA delays ruling on AstraZeneca’s breast cancer drug after negative adcomm vote
- Eli Lilly wins argument over Noom’s GLP-1 dosing claims
- Remarks at the Stanford Rock Center for Corporate Governance
- Smart ring maker Oura files confidentially for IPO as consumer demand propels revenue growth
- Outlook moves toward potential US nod for thrice-snubbed eye drug with FDA appeal win
- JD Power: Cost pressures worsen member experience with commercial plans
- Trump Admin Bars Key U.S. Researchers From Global Virus Response Talk
- Listen to the Latest ‘KFF Health News Minute’
- As calls for COINS Act expansion grow, will new rules sweep up China biotech licensing?
- Everyone Has A Family Doc, But Can You Get An Appointment?
- Many U.S. College Students With Psychosis Are Not Receiving Treatment
- Antibiotics Won't Help Ease Asthma-Linked Wheezing in Kids
- Yoga Eases Insomnia And Anxiety In Cancer Survivors, Study Finds
- Dust Yields Clues to Viral Outbreaks, Study Finds
- 3 Medical Routines That Older People May Not Need
- Acting NIAID Chief Steps Down Amid Ebola, Hantavirus Concerns
- Sunscreen Confusion Puts More Americans At Risk For Melanoma
- 1 In 10 U.S. Surgeons Quit Practice, Study Warns Of Shortage
- Video Game Can Detect Depression In Minutes, Study Says
- Quitting Smoking Might Lower Your Dementia Risk
- Severe Asthma Often Comes With Other Serious Health Problems
- Efforts To Understand The Nation's Drugged Driving Problem Stall Under Trump
- RFK Jr. Fires Two Leaders Of Major U.S. Health Task Force
- Common Food Preservatives Linked to Major Heart Problems
- Migraine With Aura Linked To Middle-Age Stroke Risk
- Nicotine Vapes Triple Smokers' Odds Of Quitting Tobacco
- Fixing Eligibility at the Point of Care: The Missing Link in Medical Device Reimbursement Integrity
- Fixing Eligibility at the Point of Care: The Missing Link in Medical Device Reimbursement Integrity
- The failure of the ‘usual suspects’ approach to life science recruitment
- The failure of the ‘usual suspects’ approach to life science recruitment
- Statement on Novel Exchange-Traded Funds (ETFs)
- Value, Focus, and the Future of MedTech: M&A and Divestitures are Rewriting the Strategic Playbook.
- Value, Focus, and the Future of MedTech: M&A and Divestitures are Rewriting the Strategic Playbook.
Prepare for more hospital charges and insurance premium hikes.
Mandates have that effect, and much more.
What are the moral implications of requiring hospitals to offer IUDs to "certain patients"? Does this refer to Medicaid patients? If so, is such discrimination constitutional?
Thursday, September 26, 2024 1:30 p.m.
AGENDA
SB 973 Sen. Cavanagh Insurance; health insurers; coverage for certain contraception; require.
SB 974 Sen. Irwin Human services; medical services; coverage for contraception and emergency contraception; require.
SB 987 Sen. McMorrow Insurance; health insurers; coverage for inpatient long-acting reversible contraceptives; require.
SB 988 Sen. McMorrow Human services; medical services; coverage for immediate postpartum intrauterine devices and contraceptive implants and associated anesthesia services; provide for.
SB 1006 Sen. McMorrow Health facilities; hospitals; hospitals stocking intrauterine devices; require and require hospitals to offer intrauterine devices to certain patients.
And any other business properly before the committee.
Michigan Senate Bill 1006 requires that Maternity Wards of all religious affiliations stock and provide contraceptives to desiring patients.
A hospital that operates a maternity unit shall ensure that an individual who is giving birth in the hospital has the option, if not medically contraindicated, of having an intrauterine device implanted after delivery and before the individual is discharged. A hospital shall ensure that a sufficient number of intrauterine devices are in stock and available at the hospital to meet the requirements of this section.
https://www.legislature.mi.gov/documents/2023-2024/billintroduced/Senate/pdf/2024-SIB-1006.pdf
The short Bill, which was supported in its Health Policy committee meeting this past Thursday, makes no exemption for Catholic Hospitals which might have a religious dispute with furnishing contraceptives to patients. This may prove to create a dispute between the Legislature and religiously affiliated Healthcare Systems.
Meeting Notes for Thursday's committee: https://committees.senate.michigan.gov/committees/ViewDocument/?apn=2023_2024_session%2Fcommittee%2Fsenate%2Fstanding%2Fhealth_policy%2Fmeetings%2F2024-09-26-1%2Fdocuments%2Ftestimony%2FAmy%20Zaagman%20MCMCH%20Support%20SBs%20973%20974%20987%20988%201006.pdf
Lest we forget the breast cancer implications here, the risk was reiterated last week.
MedPage reports JAMA's publication of a recent Danish study.
Methodology is clipped for length, but worth reading.
https://www.medpagetoday.com/hematologyoncology/breastcancer/112451
Hormonal IUDs Linked to Increased Breast Cancer Risk
— Absolute risk remains low, however
During follow-up of almost 7 years, hormone-releasing IUD use conferred a 40% higher risk of breast cancer. The data showed a trend toward increasing risk with duration of IUD use, reaching 80% among women who reported using the devices for 10-15 years.
The differences translated into excess breast cancer diagnoses that ranged from 14 to 71 per 10,000 users, although a trend analysis proved to be nonsignificant, reported Lina Steinrud Mørch, PhD, of the Danish Cancer Institute in Copenhagen, and co-authors in JAMA.
"Given the increase in LNG-IUS [levonorgestrel intrauterine systems] among females at an age with some risk for breast cancer, and its likely long-term use, information about breast cancer risk should accompany discussions about benefits and risks," the authors stated. In a prior study, "the HR [hazard ratio] with short-term LNG-IUS use was similar to that of contraceptive pills (1.2, 95% CI 1.1-1.3)."
But that earlier research could not address the duration of continuous use, and prior studies have not adequately accounted for use of other types of hormonal contraceptives.
The new results add to existing evidence suggesting an association between hormonal contraception and breast cancer, and are consistent with a recent study showing a 29% greater relative risk for breast cancer among BRCA1 carriers who used any type of hormonal contraceptive.
To examine breast cancer risk by duration of LNG-IUS use, Mørch and colleagues queried Danish national healthcare registries to identify first-time users of LNG-IUS, ages 15-49, during 2000-2019. Users of other hormonal contraceptives within the previous 5 years were excluded.
The search identified 78,595 new users of LNG-IUS who were matched to 78,595 non-users of hormonal contraceptives. The study population had a mean age of 38. Mean duration of follow-up was 6.8 years for the entire population, including 5.9 years for the LNG-IUS users and 7.7 years for the non-users.
<clip>
It seems Gov. Whitmer was not content with the legislature's pace on these bills.
Yesterday, several news sources broke the news of her executive order mandating insurance cover birth control pills, even the over-the-counter kinds.
Quoting Fox 17 News here. MLive's story is behind paywall.
Michigan to roll out free contraceptives program next month
The state of Michigan is launching a new program in November that will guarantee free access to contraception.LANSING, Mich. — The state of Michigan is launching a new program in November that will guarantee free access to contraception.
The “Take Control of Your Birth Control” program allows participating community partners and federally qualified health centers the ability to distribute free condoms, birth control and emergency contraception to Michiganders.
Recipients will also be given information that will enable them to make informed decisions on their reproductive health.
“We always want people to know what health resources that are available, especially if health options are available for free or low cost. I think it's our duty to really educate them,” says Dr. Natasha Bagdasarian, chief medical executive at the Michigan Department of Health and Human Services. “It's our role to really make sure that people have the best information possible so that they can make decisions about their health and their bodies that work for them.”
The program lasts through November.
The state expects to publish a full list of participating organizations — and an interactive map of their locations — on its website before next Friday.
Marquette WLUC's Colin Jackson included a detail not reported elsewhere:
"Contraceptive items will be distributed until supplies run out."
Fascinating thought.
One wonders how he reached it. Because it's spelled out in the EO?
Because everyone knows this market challenge will cause shortages?
Or - ??
Back in August, Michigan Public's Tracy Samilton reported some of the back room dealing on these bills.
Importantly, mandating insurance coverage for over the counter birth control negates competitive price drops.
Expect health insurance rates to rise, since this also returns cost burden to insurance premiums and taxpayers.
New state Senate bills would expand insurance coverage of birth control
Bills introduced this week (SB 973, SB 974) in the state Senate would expand what kind of birth control health insurance plans in Michigan would be required to cover.
Federal law requires Medicaid and nearly all private health insurance plans to cover many kinds of contraceptive drugs requiring a prescription, without copays -- but not over the counter types of birth control like the recently approved Opill, or the emergency contraception drug Plan B.
New bills introduced in the state Senate would require Michigan health insurance plans to cover these over-the-counter birth control drugs as well.
The Michigan Association of Health Plans says it supports maintaining access to contraceptive drugs — while it plans to work with the bills' sponsors to better understand the intent of the bills, and evaluate their impact on health insurance cost and affordability.
Meanwhile, these bills (and more) are still on this committee's action list. They might be worth a conversation next time you see a legislator.
One day before Gov. Whitmer's announced free BCP, the Biden Administration proposed a federal rule to do the same thing. Coordinated? Or one-upmanship?
In Michigan, of course, taxpayers actually pick up the tab. In this case, funds from MDHHS's family planning budget, which the legislature expanded this year by 5.6M.
In Washington's plan, we'll still be picking up the tab, just with a larger bureaucracy. On the plus side, the feds operate under rulemaking procedures, and the public comment period is open. Anyone concerned about this can give their two cents.
Morning Brew reported the DC side of the story.
White House wants to make over-the-counter birth control free
Insurers might be required to offer full coverage of OTC birth control pill and other contraceptives.
By Sam Klebanov | October 22, 2024The Biden administration unveiled a proposed rule yesterday that would require private insurers to pick up the tab for all prescriptionless birth control.
Insurance companies are already mandated to offer 100% coverage of some prescription contraceptives (thanks, Obamacare), but the 2010 law doesn’t address over-the-counter birth control pills, which only recently arrived in the US.
Removing barriers to birth control
The FDA approved an OTC birth control pill, Opill, for the first time last year. But Opill sells for $19.99 per month, so many women with private insurance looking for free access to birth control may not be able to get it. The same often goes for prescribed contraceptives: Reproductive rights activists say that some of the latest birth control methods that are associated with fewer side effects aren’t 100% covered by many insurance plans.
Biden’s rule aims to fix this by also requiring insurers to fully cover a greater variety of IUDs and other products that may appear in a sex-ed curriculum.
Looking ahead: The birth control access push comes just two weeks before the presidential election, in which family planning has been a major flashpoint. The next White House occupant will get to decide whether the proposal goes into effect.
Finally, readers will recall that pharmacist-prescribing or "almost over the counter" was proposed for the same drug not long ago.
The third leg of the state-federal-industry tango showed up in a bill package posted here six months ago
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.















